Treating hepatitis C by blocking a cellular microRNA
See on Scoop.it – Virology and Bioinformatics from Virology.ca
The results of a phase 2b human clinical trial in HCV infected humans indicate that Miravirsen reduces levels of viral RNA without evidence for viral resistance.
See on www.virology.ws